Healthcare and tech lead momentum signals in swing trading screener
The EverHint Momentum Swing Pack identified 50 high-potential stocks for short-term trading, with healthcare dominating the list at 25 signals. The top-ranked stocks included Arthur J. Gallagher & Co. and Assurant, while technology firms like Bentley Systems and Tyler Technologies also featured prominently among those showing strong momentum indicators such as volume surges and RSI strength.
On November 2, 2026, the EverHint Momentum Swing Pack identified 50 high-potential stocks for short-term swing trading, with healthcare dominating the list at 25 signals—nearly half of the total. The top-ranked picks included Arthur J. Gallagher & Co. (AJG) and Assurant, Inc. (AIZ), both in financial services but showing strong momentum indicators such as volume surges and elevated RSI readings. Technology firms Bentley Systems (BSY) and Tyler Technologies (TYL) also featured prominently, particularly within breakout and large-cap screening variants. The screener uses a composite momentum score to rank stocks, with AJG and BSY both scoring 1.00—the highest possible—indicating exceptional strength across RSI, volume, and price confirmation. Notably, CSX Corporation was the only stock flagged for insider selling within the past seven days, with a reported $999,180 in sales, though it still appeared in multiple high-momentum categories including breakout and large-cap screens. The screening process excludes stocks near earnings announcements by seven days to reduce volatility risk and requires minimum average daily volume of $25 million. These signals are intended for 1-4 week holding periods, reflecting a medium-high risk profile suited to active traders.
The momentum strategy relies on technical indicators rather than fundamental analysis, focusing on price behavior and market sentiment. The dominance of healthcare in the list—particularly West Pharmaceutical Services (WST),
The EverHint Momentum Swing Pack’s focus on healthcare and technology stocks reflects broader market trends where innovation-driven sectors continue to attract short-term capital. With 25 of 50 signals in healthcare—spanning pharmaceuticals, medical devices, and biotech—this could signal growing investor confidence in sector-specific recovery or regulatory tailwinds not detailed in the report. The prominence of firms like Regeneron (REGN) at $961 per share and West Pharmaceutical Services (WST) near $408 suggests that high-priced, large-cap healthcare stocks are seen as stable momentum plays despite volatility risks. Technology names such as Bentley Systems (BSY) and Tyler Technologies (TYL) may benefit from sustained digital transformation in infrastructure and public services, though their inclusion is based purely on technical indicators. The presence of insider selling at CSX Corporation, while limited to one stock, introduces cautionary context—highlighting that strong momentum do